The following is a summary of “Left ventricular systolic function after percutaneous coronary intervention: patterns of ...

CORXEL (formerly Ji Xing) acquired the rights to develop and commercialize aficamten in Greater China (including the Chinese mainland, Hong Kong SAR and Macau SAR, and Taiwan) from Cytokinetics in ...

Touchy topics, timely analysis, tips for tackling entrenched problems: enjoy some of TCTMD’s best features this year.

UK: In a secondary analysis of the FINEARTS-HF randomized clinical trial, researchers found that finerenone, a novel ...

In the U.S., atrial fibrillation (AF), a heart condition that causes an irregular heartbeat in the upper chambers of the ...

New research shows that cardiac MRI can predict sudden cardiac events in Fontan circulation, aiding clinical risk assessment.

A recent groundbreaking study found that in patients having Heart failure with mildly reduced ejection fraction (HFmrEF) ...

In the U.S., atrial fibrillation (AF), a heart condition that causes an irregular heartbeat in the upper chambers of the heart, affects up to one in three people in their lifetime. Significant ...

Patients who have heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and high body mass index ...

Here are the highlights from the 2024 ESC Congress. You can check out more of our coverage and interviews from the meeting by ...

Discover how AI health company Anumana has joined forces with the American College of Cardiology to advance the treatment of cardiovascular disease.

Anumana has joined the American College of Cardiology's Innovation Program to accelerate the detection and treatment of ...